CTOs on the Move


 
ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with more than 4 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.resmed.com
  • 9001 Spectrum Center Blvd
    San Diego, CA USA 92123
  • Phone: 858.836.5000

Executives

Name Title Contact Details
Urvashi Tyagi
Chief Technology Officer Profile
Sophia Mahmood
Director IT Strategic Initiatives Profile
Justin Condon
Director of Information Security Profile
Kaushik Ghoshal
Chief Technology Officer Profile
Kaushik Ghoshal
President, SaaS Business Unit Profile

Funding

ResMed raised $500M on 07/15/2019

Similar Companies

Kinetic Instruments

Kinetic Instruments is a Bethel, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Orqis Medical Corporation

Orqis Medical Corporation is a Lake Forest, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Digirad Corporation

Digirad Corporation is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

AWAK Technologies

AWAK is a patient-centric medical technology company with a mission to enhance the lives of dialysis patients and their caregivers by providing solutions to deliver better outcomes along with improving their quality of life.

TriVascular

TriVascular has pioneered numerous design and manufacturing technologies in pursuit of our commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular`s initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, TriVascular`s products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR.